These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 36946044)

  • 1. [Lnc-TMEM132D-AS1 overexpression reduces sensitivity of non-small cell lung cancer cells to osimertinib].
    Zhao Q; Wang N; Li Y; Wu Q; Wu L
    Nan Fang Yi Ke Da Xue Xue Bao; 2023 Feb; 43(2):242-250. PubMed ID: 36946044
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lnc-TMEM132D-AS1 as a potential therapeutic target for acquired resistance to osimertinib in non-small-cell lung cancer.
    Wang N; Zhao Q; Huang Y; Wen C; Li Y; Bao M; Wu L
    Mol Omics; 2023 Mar; 19(3):238-251. PubMed ID: 36651104
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Overexpression of lncRNA FEZF1-AS1 promotes progression of non-small cell lung cancer
    Li F; Xiang J; Liu J; Wang X; Jiang H
    Nan Fang Yi Ke Da Xue Xue Bao; 2024 May; 44(5):841-850. PubMed ID: 38862441
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IncRNA EPB41L4A-AS1 Mitigates the Proliferation of Non-Small-Cell Lung Cancer Cells through the miR-105-5p/GIMAP6 Axis.
    Dong B; Zhang F; Zhang W; Gao Y
    Crit Rev Eukaryot Gene Expr; 2023; 33(2):27-40. PubMed ID: 36734855
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lnc-GAN1 expression is associated with good survival and suppresses tumor progression by sponging mir-26a-5p to activate PTEN signaling in non-small cell lung cancer.
    Wang RQ; Long XR; Zhou NN; Chen DN; Zhang MY; Wen ZS; Zhang LJ; He FZ; Zhou ZL; Mai SJ; Wang HY
    J Exp Clin Cancer Res; 2021 Jan; 40(1):9. PubMed ID: 33407724
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exosomal long noncoding RNA MLETA1 promotes tumor progression and metastasis by regulating the miR-186-5p/EGFR and miR-497-5p/IGF1R axes in non-small cell lung cancer.
    Hsu XR; Wu JE; Wu YY; Hsiao SY; Liang JL; Wu YJ; Tung CH; Huang MF; Lin MS; Yang PC; Chen YL; Hong TM
    J Exp Clin Cancer Res; 2023 Oct; 42(1):283. PubMed ID: 37880793
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Knockdown of lncRNA DLX6-AS1 inhibits cell proliferation, migration and invasion while promotes apoptosis by downregulating PRR11 expression and upregulating miR-144 in non-small cell lung cancer.
    Huang Y; Ni R; Wang J; Liu Y
    Biomed Pharmacother; 2019 Jan; 109():1851-1859. PubMed ID: 30551440
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Lnc LINC00461/miR-30a-5p facilitates progression and malignancy in non-small cell lung cancer via regulating ZEB2.
    Li X; Liu J; Liu M; Xia C; Zhao Q
    Cell Cycle; 2020 Apr; 19(7):825-836. PubMed ID: 32106756
    [TBL] [Abstract][Full Text] [Related]  

  • 9. STAT1-induced upregulation of lncRNA KTN1-AS1 predicts poor prognosis and facilitates non-small cell lung cancer progression via miR-23b/DEPDC1 axis.
    Liu C; Li X; Hao Y; Wang F; Cheng Z; Geng H; Geng D
    Aging (Albany NY); 2020 May; 12(9):8680-8701. PubMed ID: 32396871
    [TBL] [Abstract][Full Text] [Related]  

  • 10. lncRNA HNF1A-AS1 modulates non-small cell lung cancer progression by targeting miR-149-5p/Cdk6.
    Liu L; Chen Y; Li Q; Duan P
    J Cell Biochem; 2019 Nov; 120(11):18736-18750. PubMed ID: 31243821
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Peptide Encoded by a Long Non-Coding RNA DLX6-AS1 Facilitates Cell Proliferation, Migration, and Invasion by Activating the wnt/β-Catenin Signaling Pathway in Non-Small-Cell Lung Cancer Cell.
    Xu X; Zhang Y; Wang M; Zhang X; Jiang W; Wu S; Ti X
    Crit Rev Eukaryot Gene Expr; 2022; 32(8):43-53. PubMed ID: 36017915
    [TBL] [Abstract][Full Text] [Related]  

  • 12. microRNA-301b-3p downregulation underlies a novel inhibitory role of long non-coding RNA MBNL1-AS1 in non-small cell lung cancer.
    Li P; Xing W; Xu J; Yuan D; Liang G; Liu B; Ma H
    Stem Cell Res Ther; 2019 May; 10(1):144. PubMed ID: 31113460
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long non-coding RNA FGD5-AS1 promotes non-small cell lung cancer cell proliferation through sponging hsa-miR-107 to up-regulate FGFRL1.
    Fan Y; Li H; Yu Z; Dong W; Cui X; Ma J; Li S
    Biosci Rep; 2020 Jan; 40(1):. PubMed ID: 31919528
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LncRNA FOXP4-AS promotes the progression of non-small cell lung cancer by regulating the miR-3184-5p/EIF5A axis.
    Li D; Li Z; YanFei W; Wang Y; Shi J; Liu C; Qu L; Deng S; Xiong D
    J Tissue Eng Regen Med; 2022 Apr; 16(4):335-345. PubMed ID: 34921595
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LncRNA CCDC144NL-AS1 Serves as a Prognosis Biomarker for Non-small Cell Lung Cancer and Promotes Cellular Function by Targeting miR-490-3p.
    Zhang L; Chi B; Chai J; Qin L; Zhang G; Hua P; Jin C
    Mol Biotechnol; 2021 Oct; 63(10):933-940. PubMed ID: 34115289
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LncRNA NCK1-AS1 promotes non-small cell lung cancer progression via regulating miR-512-5p/p21 axis.
    Luo X; Zhou J; Quan L; Liang Y; Huang P; Chen F; Liu S
    Pathol Res Pract; 2020 Nov; 216(11):153157. PubMed ID: 32858372
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exosomal long non-coding RNA MSTRG.292666.16 is associated with osimertinib (AZD9291) resistance in non-small cell lung cancer.
    Deng Q; Fang Q; Xie B; Sun H; Bao Y; Zhou S
    Aging (Albany NY); 2020 May; 12(9):8001-8015. PubMed ID: 32375124
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long non-coding RNA DLGAP1-AS1 modulates the development of non-small-cell lung cancer via the microRNA-193a-5p/DTL axis.
    Pan X; Chen S; Ye L; Xu S; Wang L; Sun Y
    Lab Invest; 2022 Nov; 102(11):1182-1191. PubMed ID: 36183046
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long non-coding RNA FENDRR inhibits NSCLC cell growth and aggressiveness by sponging miR-761.
    Zhang MY; Zhang ZL; Cui HX; Wang RK; Fu L
    Eur Rev Med Pharmacol Sci; 2018 Dec; 22(23):8324-8332. PubMed ID: 30556873
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DLX6-AS1 activated by H3K4me1 enhanced secondary cisplatin resistance of lung squamous cell carcinoma through modulating miR-181a-5p/miR-382-5p/CELF1 axis.
    Zhao X; Wang J; Zhu R; Zhang J; Zhang Y
    Sci Rep; 2021 Oct; 11(1):21014. PubMed ID: 34697393
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.